CombiMatrix Corporation Announces it Has Regained Compliance With Nasdaq Minimum Stockholders' Equity Requirement

Published: Aug 21, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

IRVINE, Calif., Aug. 21, 2013 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that in a letter dated August 20, 2013, from the Director of Listing Qualifications of The Nasdaq Stock Market LLC, the Company was informed that it has regained compliance with Listing Rule 5550(b)(1) (the Rule), which requires a minimum of $2.5 million stockholders' equity for The Nasdaq Capital Market.

Help employers find you! Check out all the jobs and post your resume.

Back to news